Organization · Venture Capital
HMW Kapitalanlagen
HMW Kapitalanlagen is a private equity firm based in Pullach, Germany, specializing in deep-tech and life sciences investments. It connects capital with innovative visions through tailored investment solutions for retail and affluent investors.
Overview
What HMW Kapitalanlagen does
What HMW Kapitalanlagen is
HMW Kapitalanlagen is a private equity firm based in Pullach, Germany, specializing in deep-tech and life sciences investments. It connects capital with innovative visions through tailored investment solutions for retail and affluent investors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find HMW Kapitalanlagen elsewhere
Open the official website or a supported primary organization account.
Capability profile
HMW Kapitalanlagen as a funder
Investment thesis
HMW Kapitalanlagen focuses on deep tech and life sciences, investing in breakthrough pharmaceuticals, AI, quantum technologies, and sustainable materials. The firm aims to connect capital with innovative visions, primarily targeting European-founded companies.
Focus narrative
HMW Kapitalanlagen specializes in private equity investments, particularly in automation and robotics, digital innovation, and biotechnology and medical technology. Their investment strategies include the MIG Fonds and the ELTIF RockPhant, which target growth-oriented companies and technologies that shape the future.
Value beyond capital
HMW Kapitalanlagen provides significant value to its portfolio companies through its deep expertise in deep tech and life sciences, access to a network of investors, and a commitment to long-term growth. The firm is known for meaningful lead-check participation in complex technical rounds, particularly in biotech and sustainable materials.
Terms and economics
- Typical check
- $1,000,000–$10,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Seed · Series A · Series B
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 30
- Recorded notable exits
- BioNTech, Immatics, and Siltectra
Portfolio context
HMW Kapitalanlagen has invested in notable companies such as BioNTech, known for its mRNA technology and COVID-19 vaccine development, and Immatics, a T-cell immunotherapy biotech. The firm also has a stake in Siltectra, a deep-tech company specializing in silicon wafer splitting, which was acquired by Infineon.
Common questions
What to know about HMW Kapitalanlagen
Upseed classifies HMW Kapitalanlagen under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.